A recent trial showed that nicotinamide riboside supplementation might reduce airway inflammation in patients with COPD who ...

Explore strategies for controlling COPD and improving health, with a focus on management and lifestyle changes.

After waking up from the procedure, he told me he could take full breaths for the first time in years,” Dr. Mark Sigler said ...

Tezepelumab did not significantly decrease moderate or severe COPD exacerbations compared with placebo, the COURSE trial found.

We've all felt winded when taking the stairs or dealt with a cough from time to time. But if these issues linger, they could ...

AstraZeneca’s respiratory and immunology portfolio is driving significant growth, with R&I assets forecasted to account for ...

“Preventing unnecessary exposure to air pollution and consistently wearing masks in high-risk environments can significantly ...

Chronic obstructive pulmonary disease (COPD) can result from chronic ... Symptoms can include: These symptoms usually worsen over time without treatment. You can also develop conditions like ...

For the first time Australian researchers have identified how exposure to smoking may cause a deadly lung disease that claims ...

Objective: To investigate the efficacy and tolerability of high-dose N-acetylcysteine (NAC) in the treatment of patients with exacerbations of chronic obstructive pulmonary disease (COPD).

New Study Shows Promising Results for COPD Treatment Nov. 20 ... Sep. 26, 2024 — What factors lead to chronic respiratory disease? Researchers investigated this question using health data ...